Can varicose veins recur after treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Varicose Veins Can and Do Recur After Treatment

Yes, varicose veins frequently recur after treatment, with recurrence rates ranging from 20-28% at 5 years even with appropriate surgical intervention, and higher rates (up to 47-66%) when measured by clinical and physiologic criteria. 1, 2, 3

Understanding Recurrence Rates by Treatment Type

Surgical Treatment Recurrence

  • Traditional surgical stripping has a 5-year recurrence rate of 20-28%, even when performed correctly 1
  • At the saphenofemoral junction, recurrence occurs in 1% at 1 year but increases to 23% by 3 years 3
  • At the saphenopopliteal junction, recurrence is higher: 25% at 1 year, escalating to 52% by 3 years 3
  • Clinical recurrence reaches 47.1% at 5 years, with physiologic recurrence (measured by venous filling index) occurring in 66% of limbs 3

Endovenous Thermal Ablation Recurrence

  • Radiofrequency ablation achieves 91-100% occlusion rates at 1 year, representing superior short-term outcomes compared to surgery 1, 4
  • However, long-term recurrence still occurs at rates of 15-35% by 2 years post-intervention 5, 1

Foam Sclerotherapy Recurrence

  • Foam sclerotherapy demonstrates 72-89% occlusion rates at 1 year 1, 6
  • Chemical sclerotherapy alone has significantly worse outcomes at 1-, 5-, and 8-year follow-ups compared to thermal ablation, with higher rates of recurrent GSV reflux and saphenofemoral junction failure 1, 6

Primary Mechanisms of Recurrence

1. Incomplete Initial Treatment

  • Inadequate surgery at major junctions contributes to recurrence in 7.2% of limbs 3
  • Failure to treat saphenofemoral junction reflux is a critical factor, as untreated junctional reflux causes persistent downstream pressure leading to tributary vein recurrence 1, 6
  • Failure to ligate perforating veins is identified as a major contributor, with 92.7% of recurrent cases showing perforating vein insufficiency 7

2. Neovascularization

  • Neovascular reconnection at the saphenofemoral junction is a major contributor to late recurrence, occurring even after technically adequate initial surgery 3
  • This represents new vessel formation connecting the superficial and deep venous systems 8, 9

3. Disease Progression

  • Persistent abnormal venous function predicts recurrence, with 29 of 53 limbs that had normal venous filling index post-operatively deteriorating by 3 years 3
  • Incompetent perforator vessels increase progressively in number over time 3
  • 78.9% of recurrent cases show reflux of the superficial femoral vein of varying severity 7

4. Residual Untreated Disease

  • 75.2% of recurrent cases had residual saphenous vein that was not adequately treated initially 7
  • 17.4% had blocked iliac veins due to post-thrombotic syndrome, representing upstream obstruction 7

Predictors of Recurrence

Limbs with the following characteristics at 3 weeks post-treatment are at highest risk:

  • Multiple sites of reflux preoperatively 3
  • Venous filling index >2 mL/s 3
  • Persistent abnormality at duplex scanning 3

Notably, 40 limbs with normal findings at 3 weeks had zero recurrence, demonstrating the importance of complete initial treatment 3

Critical Treatment Principles to Minimize Recurrence

Mandatory Pre-Treatment Assessment

  • Comprehensive duplex ultrasound within 6 months is essential, documenting reflux duration ≥500ms, exact vein diameters, and all sites of incompetence 1, 4, 6
  • Preoperative imaging must identify all perforating vein insufficiency to guide complete surgical intervention 7

Treatment Sequencing Matters

  • Endovenous thermal ablation must be performed first for saphenofemoral or saphenopopliteal junction reflux (veins ≥4.5mm diameter) 1, 4
  • Sclerotherapy should be reserved for tributary veins (2.5-4.5mm diameter) as adjunctive treatment, not primary therapy 1, 6
  • Treating tributary veins alone without addressing junctional reflux results in 20-28% recurrence at 5 years 1

Anatomic Considerations

  • Careful dissection of the saphenofemoral junction combined with stripping to just below the knee is the best approach to prevent recurrence from the great saphenous vein 8
  • Preoperative location of the exact level of the saphenopopliteal junction is critical, as this junction has higher recurrence rates 8, 3

Common Pitfalls Leading to Recurrence

  1. Treating only visible varicose veins without addressing underlying junctional reflux 1, 6
  2. Using sclerotherapy as monotherapy for veins that require thermal ablation (diameter ≥4.5mm) 1
  3. Inadequate preoperative duplex assessment failing to identify all sources of reflux 7
  4. Failure to treat perforating vein insufficiency when present 7, 3
  5. Insufficient follow-up imaging at 3 weeks to identify incomplete treatment before clinical recurrence develops 3

Post-Treatment Surveillance

Early postoperative duplex scans at 2-7 days are mandatory to detect endovenous heat-induced thrombosis and assess treatment adequacy 1, 4

Follow-up at 3 weeks identifies patients at risk for recurrence, allowing for early intervention before clinical deterioration 3

References

Guideline

Varithena and Foam Sclerotherapy for Venous Insufficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Radiofrequency Ablation for Symptomatic Varicose Veins

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medical Necessity of Sclerotherapy for Varicose Veins

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Analysis of a series of patients with varicose vein recurrence.

The Journal of international medical research, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.